Hepatoblastoma clinical research

Lessons learned and future challenges

Giorgio Perilongo, Marcio Malogolowkin, James Feusner

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

The past four decades has brought significant improvement to the diagnosis, treatment, and outcomes of children diagnosed with hepatoblastoma. These improvements are the results of multidisciplinary and multi-institutional international cooperative trials, such as those conducted by the Children's Oncology Group (COG) or the International Childhood Liver Tumor Strategy Group (SIOPEL) and national studies such as those conducted in Germany and Japan. Due to the different treatment strategies used by the various groups, the information generated has been at times complementary but at other times contradictory. In this manuscript, we will provide a global picture of where "we stand and where we are going" in regards to clinical research of childhood hepatoblastoma. We will focus on lessons learned, especially in reference to the experiences of the COG and SIOPEL study groups, and discuss future challenges.

Original languageEnglish (US)
Pages (from-to)818-821
Number of pages4
JournalPediatric Blood and Cancer
Volume59
Issue number5
DOIs
StatePublished - Nov 1 2012
Externally publishedYes

Fingerprint

Hepatoblastoma
Research
Germany
Japan
Liver
Neoplasms
Therapeutics

Keywords

  • Chemotherapy for hepatoblastoma
  • PRETEXT system
  • Tumor resection

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Hepatoblastoma clinical research : Lessons learned and future challenges. / Perilongo, Giorgio; Malogolowkin, Marcio; Feusner, James.

In: Pediatric Blood and Cancer, Vol. 59, No. 5, 01.11.2012, p. 818-821.

Research output: Contribution to journalReview article

Perilongo, Giorgio ; Malogolowkin, Marcio ; Feusner, James. / Hepatoblastoma clinical research : Lessons learned and future challenges. In: Pediatric Blood and Cancer. 2012 ; Vol. 59, No. 5. pp. 818-821.
@article{d97f014df45f46baa1e4027efb4e5c0e,
title = "Hepatoblastoma clinical research: Lessons learned and future challenges",
abstract = "The past four decades has brought significant improvement to the diagnosis, treatment, and outcomes of children diagnosed with hepatoblastoma. These improvements are the results of multidisciplinary and multi-institutional international cooperative trials, such as those conducted by the Children's Oncology Group (COG) or the International Childhood Liver Tumor Strategy Group (SIOPEL) and national studies such as those conducted in Germany and Japan. Due to the different treatment strategies used by the various groups, the information generated has been at times complementary but at other times contradictory. In this manuscript, we will provide a global picture of where {"}we stand and where we are going{"} in regards to clinical research of childhood hepatoblastoma. We will focus on lessons learned, especially in reference to the experiences of the COG and SIOPEL study groups, and discuss future challenges.",
keywords = "Chemotherapy for hepatoblastoma, PRETEXT system, Tumor resection",
author = "Giorgio Perilongo and Marcio Malogolowkin and James Feusner",
year = "2012",
month = "11",
day = "1",
doi = "10.1002/pbc.24217",
language = "English (US)",
volume = "59",
pages = "818--821",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Hepatoblastoma clinical research

T2 - Lessons learned and future challenges

AU - Perilongo, Giorgio

AU - Malogolowkin, Marcio

AU - Feusner, James

PY - 2012/11/1

Y1 - 2012/11/1

N2 - The past four decades has brought significant improvement to the diagnosis, treatment, and outcomes of children diagnosed with hepatoblastoma. These improvements are the results of multidisciplinary and multi-institutional international cooperative trials, such as those conducted by the Children's Oncology Group (COG) or the International Childhood Liver Tumor Strategy Group (SIOPEL) and national studies such as those conducted in Germany and Japan. Due to the different treatment strategies used by the various groups, the information generated has been at times complementary but at other times contradictory. In this manuscript, we will provide a global picture of where "we stand and where we are going" in regards to clinical research of childhood hepatoblastoma. We will focus on lessons learned, especially in reference to the experiences of the COG and SIOPEL study groups, and discuss future challenges.

AB - The past four decades has brought significant improvement to the diagnosis, treatment, and outcomes of children diagnosed with hepatoblastoma. These improvements are the results of multidisciplinary and multi-institutional international cooperative trials, such as those conducted by the Children's Oncology Group (COG) or the International Childhood Liver Tumor Strategy Group (SIOPEL) and national studies such as those conducted in Germany and Japan. Due to the different treatment strategies used by the various groups, the information generated has been at times complementary but at other times contradictory. In this manuscript, we will provide a global picture of where "we stand and where we are going" in regards to clinical research of childhood hepatoblastoma. We will focus on lessons learned, especially in reference to the experiences of the COG and SIOPEL study groups, and discuss future challenges.

KW - Chemotherapy for hepatoblastoma

KW - PRETEXT system

KW - Tumor resection

UR - http://www.scopus.com/inward/record.url?scp=84866162300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866162300&partnerID=8YFLogxK

U2 - 10.1002/pbc.24217

DO - 10.1002/pbc.24217

M3 - Review article

VL - 59

SP - 818

EP - 821

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 5

ER -